Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.06.2016 | case report

Intravascular large B‑cell lymphoma

A rare and potentially reversible cause of cerebral stroke

verfasst von: Silvia Hofer, MD, Manfred Kessler, MD, Jeanne Godau, MD, Daniela Weiler, MD, Karl Frontzek, MD, Elisabeth Jane Rushing, MD, Stefan Aebi, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Intravascular lymphoma (IVL), a rare, extranodal form of non-Hodgkin lymphoma (NHL), can cause infarcts by occluding small arteries of the brain. Owing to its heterogeneous clinical manifestations and unfavorable prognosis, the diagnosis is often made postmortem. Patients can present with a range of motor or sensory deficits, rapid cognitive impairment, aphasia or signs of myelitis, often with nonspecific radiographic findings.Timely recognition of a treatable disease is essential to prevent permanent neurocognitive defects. We present a case who could be treated successfully with chemotherapy.
Vorheriger Artikel memo—new frontiers to be reached
Nächster Artikel Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
Literatur
1.
Ponzoni M, Arrigoni G, Gould VE, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31:220–226.CrossRefPubMed
2.
Swerdlow SH, Campo E, Harris NL. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC; 2008.
3.
Zuckerman D, Seliem R, Hochberg E. Intravascular Lymphoma: the Oncologist’s “great imitator”. Oncologist. 2006;11:496–502.CrossRefPubMed
4.
Ferreri AJ, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. Br J Haematol. 2004;127:173–183.CrossRefPubMed
5.
Shimada K, Kinoshita T, Naoe T, et al. Presentation and management of intravascular large B‑cell lymphoma. Lancet Oncol. 2009;10:895–902.CrossRefPubMed
6.
Beristain X, Azzarelli B. The neurological masquerade of intravascular lymphomatosis. Arch Neurol. 2002;59:439–443.CrossRefPubMed
7.
Heinrich A, Vogelgesang S, Kirsch M, et al. Intravascular lymphomatosis presenting as rapidly progressive dementia. Eur Neurol. 2005;54:55–58.CrossRefPubMed
8.
Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B‑cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B‑cell lymphoma associated with haemo-phagocytic syndrome. Br J Haematol. 2000;111:826–834.PubMed
9.
Pongpudpunth M, Rattanakaemakorn P, Fleischer A. Usefulness of random skin biopsy as a diagnostic tool of Intravascular Lymphoma presenting with fever of unknown origin. Am J Dermatopathol. 2015;37(9):686–690.CrossRefPubMed
10.
Shimada K, Matsue K, Yamamoto K, et al. Retrospective analysis of intravascular large B‑cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008;26:3189–3195.CrossRefPubMed
11.
Shimada K, Murase T, Matsue K, et al. Central nervous system involvement in intravascular large B‑cell lymphoma: A retrospective analysis of 109 patients. Cancer Sci. 2010;101:1480–1486.CrossRefPubMed
12.
Sawada T, Omuro Y, Kobayashi T, et al. Long-term complete remission in a patient with intravascular large B‑cell lymphoma with central nervous system involvement. Onco Targets Ther. 2014;7:2133–2136.CrossRefPubMedPubMedCentral
13.
Fonkern E, Lok E, Robison D, et al. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3(4):1010–1024.CrossRef
Metadaten
Titel
Intravascular large B‑cell lymphoma
A rare and potentially reversible cause of cerebral stroke
verfasst von
Silvia Hofer, MD
Manfred Kessler, MD
Jeanne Godau, MD
Daniela Weiler, MD
Karl Frontzek, MD
Elisabeth Jane Rushing, MD
Stefan Aebi, MD
Publikationsdatum
01.06.2016
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2016
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-016-0262-8

Weitere Artikel der Ausgabe 2/2016

memo—new frontiers to be reached

  • editorial

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option

  • Open Access
  • case report

Initial emergencies in children and adolescents with malignant hematologic–oncological diseases

  • review

Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer

  • original report

Immune checkpoint blockade in ovarian cancer

  • Open Access
  • short review

Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity

  • case report